Q&A With Paul Kwo From Indiana University: Hepatitis C Treatment Helps Reduce Need for Liver Transplant

Video

It was not long ago that patients with hepatitis C were among the leading candidates for liver transplants. Now that many forms of the disease are curable that attention can be turned to other patients in need.

It was not long ago that patients with hepatitis C were among the leading candidates for liver transplants. Now that many forms of the disease are curable that attention can be turned to other patients in need.

Paul Kwo, MD, from Indiana University discussed how the field has changed in recent years and what it can mean for the treatment of other liver diseases during the American College of Gastroenterology's annual meeting in Hawaii.

Related Videos
Anthony Lembo, MD | Credit: Cleveland Clinic
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Ali Rezaie, MD | Credit: X
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Paul Feuerstadt, MD | Yale School of Medicine
| Image Credit: LinkedIn
Oriana Damas, MD | Credit University of Miami
Ali Rezaie, MD | Credit: X
© 2024 MJH Life Sciences

All rights reserved.